GanD, Inc. — Department of Defense SBIR Phase I: DHA193-004
GanD, Inc. — SBIR Phase I award from Department of Defense.
- Amount
- $250,000
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase I
- Topic
- DHA193-004
- Solicitation
- 19.3
- NAICS
- —
- Place of performance
- FL
- Period
- 2020-06-15 → 2021-01-14
Description
Problem: The limited availability of blood and blood products for use in prehospital settings is a significant concern. Objective: The objective of this proposal is to use in-vitro and in-vivo studies to evaluate a manufactured, “blood-like” prototype, P